Harrow HROW Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)

Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies

Bausch + LombBLCO

$215M+0.5%

Bausch Health CompaniesBHC

$224M+0.4%

Tarsus Pharmaceuticals, Inc.TARS

$961K0.0%

PTH

Pelthos TherapeuticsPTHS

$3.82M—

TOI

TOITOI

$453K-2.2%

FAQ

What is Harrow's finite-lived intangible assets - expected amortization expense (year one)?

Harrow (HROW) reported finite-lived intangible assets - expected amortization expense (year one) of $16.58M in Q2 2026.

How has Harrow's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?

Harrow's finite-lived intangible assets - expected amortization expense (year one) increased by 3.0% year-over-year, from $16.1M to $16.58M.

What is the long-term trend for Harrow's finite-lived intangible assets - expected amortization expense (year one)?

Over 5 years (2020 to 2025), Harrow's finite-lived intangible assets - expected amortization expense (year one) has grown at a 151.9% compound annual growth rate (CAGR), from $160K to $16.21M.

What does finite-lived intangible assets - expected amortization expense (year one) mean?

This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.